Literature DB >> 7770958

Intestinal spirochetosis and acquired immunodeficiency syndrome: ultrastructural studies of two cases.

J G Guccion1, D A Benator, J Zeller, B Termanini, N Saini.   

Abstract

Two cases of intestinal spirochetosis (IS) with acquired immunodeficiency syndrome are reported. In case 1, a 48-year-old homosexual black man presented with a 1-month history of alternating watery diarrhea and constipation, which dissipated following the removal of two colonic hyperplastic polyps containing IS. In case 2, a 26-year-old homosexual black man presented with a 3-month history of persistent bloody diarrhea and was found to have chronic shigellosis and IS. Pathologic findings of IS were similar in both cases. Basophilic fringes typical of IS covered the surfacing colonic epithelium and consisted of dense growths of spirochetes adherent to and oriented perpendicular to the plasma membranes of the surfacing epithelium. The spirochetes measured 3 to 5 microns in length and 0.2 micron in width, contained four to eight axial fibrils, and closely resembled Brachyspira aalborgi ultrastructurally. These cases are notable because the histopathologic changes of IS were more extensive than generally described. There was involvement of both the right colon and rectum by IS in case 2, and in both cases there was extension of the IS down into the crypts of Lieberkühn, spirochetal invasion of the colonic mucosa, and a conspicuous inflammatory response by macrophages in the underlying lamina propria.

Entities:  

Mesh:

Year:  1995        PMID: 7770958     DOI: 10.3109/01913129509014599

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  13 in total

1.  Improvement of chronic diarrhea after treatment for intestinal spirochetosis.

Authors:  P L Peghini; J G Guccion; A Sharma
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

2.  Comparison of prevalence and risk factors for faecal carriage of the intestinal spirochaetes Brachyspira aalborgi and Brachyspira pilosicoli in four Australian populations.

Authors:  C J Brooke; T V Riley; D J Hampson
Journal:  Epidemiol Infect       Date:  2006-06       Impact factor: 2.451

Review 3.  The Spirochete Brachyspira pilosicoli, Enteric Pathogen of Animals and Humans.

Authors:  David J Hampson
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

4.  PCR amplification from fixed tissue indicates frequent involvement of Brachyspira aalborgi in human intestinal spirochetosis.

Authors:  A S Mikosza; T La; C J Brooke; C F Lindboe; P B Ward; R G Heine; J G Guccion; W B de Boer; D J Hampson
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

5.  Isolation of Serpulina pilosicoli from rectal biopsy specimens showing evidence of intestinal spirochetosis.

Authors:  N L Trivett-Moore; G L Gilbert; C L Law; D J Trott; D J Hampson
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

6.  Identification and characterization of Serpulina pilosicoli isolates recovered from the blood of critically ill patients.

Authors:  D J Trott; N S Jensen; I Saint Girons; S L Oxberry; T B Stanton; D Lindquist; D J Hampson
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

7.  Brachyspira aalborgi infection diagnosed by culture and 16S ribosomal DNA sequencing using human colonic biopsy specimens.

Authors:  W Kraaz; B Pettersson; U Thunberg; L Engstrand; C Fellström
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

Review 8.  [Human intestinal spirochetosis].

Authors:  B Knopf; B Bethke; M Stolte
Journal:  Pathologe       Date:  2003-04-03       Impact factor: 1.011

Review 9.  Human intestinal spirochetosis--a review.

Authors:  Efstathia Tsinganou; Jan-Olaf Gebbers
Journal:  Ger Med Sci       Date:  2010-01-07

10.  Human Intestinal Spirochetosis Incompatible With Dysplastic Adenomatous Epithelium.

Authors:  Cullen Lilley; Joseph Grech; Emily Martinbianco; Xiuxu Chen
Journal:  Cureus       Date:  2022-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.